Chapter 8 Blind Data Review (BDR)
The Statistician’s Final Gate Before Database Lock
Blind Data Review (BDR) represents the final and most critical checkpoint before database lock (DBL).
It is the stage at which the biostatistician must answer a high-stakes question:
Is the data, as currently collected and cleaned, fit for its intended statistical analysis?
This assessment must be made under full blinding, without access to treatment assignment, and based solely on data structure, completeness, consistency, and protocol adherence.
8.1 Why Blind Data Review Is Statistically Critical
8.1.1 BDR Is Not a Routine Data Cleaning Step
In many projects, BDR is treated as: - A procedural milestone - A Data Management–led checkpoint - A pre-DBL formality
From a statistical perspective, this view is dangerously incomplete.
BDR is the point where: - Analysis assumptions are confronted with real data - Protocol deviations become analytically meaningful - Risks to interpretability are either mitigated or locked in
Once DBL occurs: - Structural data issues cannot be corrected - Analysis population definitions become frozen - Sensitivity analyses shift from planned to defensive
For the biostatistician, BDR is the last opportunity to influence analytical integrity without regulatory consequence.
8.1.2 The Statistician’s Unique Responsibility in BDR
Unlike Data Management or Clinical Operations, statisticians do not focus on: - How data were operationally collected - Why deviations occurred at sites
Instead, statisticians assess:
What are the analytical consequences of the data as they exist today?
8.2 Statistical Support of the BDR Plan
8.2.1 Objectives of a Robust BDR Plan
A well-designed BDR Plan should: - Define the scope and timing of blinded review activities - Specify datasets, domains, and listings to be reviewed - Clarify cross-functional roles and responsibilities - Predefine outputs and decision criteria
From a statistical standpoint, the plan must ensure that: - Blinding is strictly preserved - Outputs are analysis-relevant rather than operationally excessive - Decisions are traceable and defensible
8.2.2 Statistical Contributions to the BDR Plan
Biostatisticians should actively shape: - Which summaries and listings are produced - Which metrics are considered critical for analysis readiness - Which thresholds trigger escalation or remediation
A key mindset:
BDR outputs are decision tools, not descriptive reports.
8.3 Core Review Areas During Blind Data Review
8.3.1 Data Completeness
8.3.1.1 Statistical Review Focus
Beyond simple missing value counts, statisticians should evaluate: - Completeness of primary and key secondary endpoints - Patterns of missingness across visits and time - Concentration of missing data at critical assessment points
Key questions include: - Does missingness increase over time? - Are key visits systematically incomplete? - Are reasons for missing data adequately captured?
8.3.1.2 Implications for Analysis
Incomplete data directly affect: - Effective sample size - Model stability and convergence - Justification of missing data assumptions (e.g., MAR vs MNAR)
If missingness mechanisms cannot be reasonably argued, the SAP’s missing data strategy is exposed to challenge.
8.3.2 Outliers and Extreme Values
8.3.2.1 Statistical Interpretation of Outliers
During BDR, statisticians should: - Identify extreme values without attempting correction - Assess internal consistency with related variables - Confirm that extreme values were captured rather than suppressed
A fundamental principle:
Outliers are not errors by default; they are analytical signals.